论文部分内容阅读
目的:利福喷丁与利福平治疗肺结核的临床对比研究。方法:在医院选择80位患有肺结核的患者,随机将其分为利福喷丁组与利福平组,对两组患者的临床疗效和观察指标进行对比分析。结果:两组对象的临床疗效和观察指标对比有相关性。结论:本次的研究结果表明,利福喷丁用于肺结核病的治疗,具有血药浓度稳定、抗菌活性强、毒性作用低等疗效。
Objective: The clinical comparative study of rifapentine and rifampicin in the treatment of pulmonary tuberculosis. Methods: Eighty patients with pulmonary tuberculosis were selected in the hospital. Patients were randomly divided into rifapentine group and rifampicin group. The clinical efficacy and observation indexes of the two groups were compared. Results: The clinical efficacy of the two groups of objects and the correlation between the observation indicators are relevant. Conclusion: The results of this study indicate that rifapentine is used in the treatment of pulmonary tuberculosis and has the effects of stable blood concentration, strong antibacterial activity and low toxicity.